Image via Wikipedia What’s a billion between friends?
The University of Georgia Research Foundation Inc. has filed suit claiming Allergan screwed them out of a couple hundred million bucks for a drug that’s earned the company more than a billion dollars.
Allercan filed briefs in the case opposing the unsealing of. “commercially-sensitive documents because the harm that Allergan would thereby suffer greatly outweighs any purported public interest in the contents of the documents.” I wonder what they could possibly contain?
No worries, we’re gonna find out.
The judge in the case, Judge David Sweat (great name), referring to the “bad deal” said he would begin the process of unsealing most of the documents.
I love a catfight. Especially one where a cat gets dragged through the mud.
Note to self: Don’t screw your licensor.
- Pharmagossip had it first
- Original Article (Atlanta Business Chronicle)
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=ad0b39ff-18ad-4e24-9fa5-653b3bbd28c3)
Theoretically Related Posts
Eben is a highly caffeinated business development associate at a small, cash sensitive pharmaceutical company somewhere in Massachusetts. He enjoys cliche-less banter, compartmentalization, non-equilibrium thermodynamics and NPV analysis. Agree or disagree with what he's posted? He encourages comments.
If one were so inclined, one could follow him at any of these fine web 2.0 establishments:
Feel free to leave a comment below. Eben loves comments. You may also subscribe to comments through this RSS Comments feed or trackback here.
Add New Comment
Thanks. Your comment is awaiting approval by a moderator.
Do you already have an account? Log in and claim this comment.
Add New Comment
Trackbacks
(Trackback URL)